Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: Does it really work? If yes, is it a novelty? [5] (multiple letters)

Diabetic Medicine

Volumn 22, Issue 5, 2005, Pages 666-667

  Ciardullo, A V ^a   Bennett, S M A ^b   Heise, M ^c   Jones, N P ^d   Walker, M ^b   Wilding, J P H ^e  

^a Local Health Unit   (Italy)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE; INSULIN; METFORMIN; PLACEBO; RAMIPRIL; ROSIGLITAZONE; TETRAHYDROLIPSTATIN;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; EVALUATION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GLUCOSE TOLERANCE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LETTER; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; THIAZOLIDINEDIONES;

EID: 17844402755     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01502.x     Document Type: Letter

References (0)